Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors

被引:0
|
作者
Ahmaditaba, Mohammad Ali [1 ]
Tehrani, Mohammad Hassan Houshdar [1 ]
Zarghi, Afshin [1 ]
Shahosseini, Sorayya [1 ]
Daraei, Bahram [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Chem, Tehran, Iran
[2] Tarbiat Modares Univ, Dept Toxicol, Fac Med Sci, Tehran, Iran
来源
关键词
Peptide analogue; Solid phase peptide synthesis; Wang resin; COX-2; enzyme; Inhibitor; CYCLOOXYGENASE-2; INHIBITORS; ANTIINFLAMMATORY DRUGS; MECHANISM; IDENTIFICATION; POTENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO2Me or N-3 attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC50 value of 0.08 mu M and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [1] Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors
    Ahmaditaba, Mohammad A.
    Shahosseini, Soraya
    Daraei, Bahram
    Zarghi, Afshin
    Tehrani, Mohammad H. Houshdar
    ARCHIV DER PHARMAZIE, 2017, 350 (10)
  • [2] Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors
    Kaya Cavusoglu, Betul
    Saglik, Begum N.
    Acar Cevik, Ulviye
    Osmaniye, Derya
    Levent, Serkan
    Ozkay, Yusuf
    Kaplancikli, Zafer A.
    ARCHIV DER PHARMAZIE, 2021, 354 (03)
  • [3] Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
    Badrey, Mohamed G.
    Abdel-Aziz, Hassan M.
    Gomha, Sobhi M.
    Abdalla, Mohamed M.
    Mayhoub, Abdelrahman S.
    MOLECULES, 2015, 20 (08) : 15287 - 15303
  • [4] Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors
    Mohamed, Lamia W.
    El-Badry, Osama. M.
    El-Ansary, Afaf K.
    Ismael, Ahmed
    BIOORGANIC CHEMISTRY, 2017, 72 : 308 - 314
  • [5] Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
    M. Arockia Babu
    Rakesh Shukla
    Chandishwar Nath
    S. G. Kaskhedikar
    Medicinal Chemistry Research, 2012, 21 : 2223 - 2228
  • [6] Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors
    Lu, Xiang
    Zhang, Hui
    Li, Xi
    Chen, Guo
    Li, Qing-Shan
    Luo, Yin
    Ruan, Ban-Feng
    Chen, Xian-Wei
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) : 6827 - 6832
  • [7] Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors
    Xin, Min
    Wu, Haoyu
    Du, Yuan
    Liu, Sheng
    Zhao, Feng
    Mou, Xiaofeng
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 380
  • [8] Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
    Babu, M. Arockia
    Shukla, Rakesh
    Nath, Chandishwar
    Kaskhedikar, S. G.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2223 - 2228
  • [9] Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold
    Ibrahim, Tarek S.
    Salem, Ibrahim M.
    Mostafa, Samia M.
    El-Sabbagh, Osama, I
    ElKhamisi, Mohamed K. M.
    Hegazy, Lamees
    Elgendy, Bahaa
    BIOORGANIC CHEMISTRY, 2020, 100
  • [10] Design, synthesis and biological evaluation of chalcone derivatives possessing a methanesulfonamido pharmacophore as selective COX-2 inhibitors
    Zebardast, T.
    Zarghi, A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A48 - A49